AI System BELA Revolutionizes IVF Embryo Assessment

A groundbreaking AI system, BELA, has been developed to enhance in vitro fertilization (IVF) embryo assessment, offering objective evaluations of embryo quality. This innovative platform utilizes time-lapse video and maternal age data to determine chromosomal status, potentially revolutionizing reproductive medicine and improving IVF success rates. Researchers at Weill Cornell Medicine highlight BELA’s automated approach, which could become a standard tool in clinics worldwide, providing new hope for families facing fertility challenges.